ADMA BIOLOGICS, INC.ADMA

時価総額
$44.2億
PER
2012年
12月31日
2013年
12月31日
2014年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
Cash and cash equivalents132617101043232756518751
Accounts receivable, net39,112-383,961924,468141313291627
Inventories1223513195382125163173
Prepaid expenses and other current assets107,761298,730143,586111,027313,9142233455
Total current assets1431242122634586154209270257
Total property and equipment, net779,297765,29932230303242515854
Intangible assets, net-----5432210
Goodwill-----4444444
Right-to-use assets--------471010
Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer and amount of noncurrent assets classified as other.---------455
TOTAL ASSETS163227242410889127208276348329
Accounts payable1322366911121316
Total accrued expenses and other current liabilities--------8172533
Current portion of deferred revenue---------142,834142,8340
Current portion---------591,084905,3691
Total current liabilities2444119101420303950
Senior notes payable---------95143131
Deferred revenue, net of current portion-22333222222
Principal balance of the loans and any other obligations advanced or otherwise owed.----------22
Balance at December 31, 2023---------71110
Other non-current liabilities-132,500132,50012105,996260,734106,57454,886397,351350,4540
TOTAL LIABILITIES6102123286869101119135196194
COMMITMENTS AND CONTINGENCIES------------
Preferred Stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding------------
Common Stock - voting, $0.0001 par value, 300,000,000 shares authorized, 226,063,032 and 221,816,930 shares issued and outstanding4629299291,0721,2893,6734,6355,93210,49019,58122,1820
Additional paid-in capital47747588102191236291429553630641
Accumulated deficit-37,109,328-52,636,574-69,449,737-87,419,667-106,934,818-150,693,793-216,437,238-264,716,555-340,465,103-412,112,721-478,016,671-506
Balance9226820,974-4,457,26240202688141152135
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY163227242410889127208276348329